{"gene":"TMPRSS6","run_date":"2026-06-10T10:51:55","timeline":{"discoveries":[{"year":2008,"finding":"TMPRSS6 (matriptase-2) is a liver-expressed type II transmembrane serine protease that negatively regulates hepcidin expression; loss-of-function mutations cause iron-refractory iron deficiency anemia (IRIDA) with inappropriately elevated hepcidin levels in both humans and mice.","method":"Human genetics (germline mutation identification), mouse phenotyping (Tmprss6-deficient mice), overexpression in cell lines with hepcidin promoter assays","journal":"Nature genetics / Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple independent labs simultaneously reported loss-of-function phenotype in humans and mice with concordant mechanistic findings","pmids":["18408718","18451267","18523150","18603562"],"is_preprint":false},{"year":2008,"finding":"TMPRSS6 cleaves membrane-bound hemojuvelin (HJV) on the plasma membrane; the serine protease domain is required for this cleavage, and the MASK mouse allele (lacking the protease domain) shows no cleavage activity and fails to inhibit the hepcidin-activating BMP/SMAD pathway.","method":"Cell-based cleavage assay, co-expression of TMPRSS6 and HJV in cells, zebrafish overexpression, domain-deletion analysis","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — direct substrate cleavage demonstrated in vitro with mutant comparisons, replicated by multiple labs in complementary models","pmids":["18976966"],"is_preprint":false},{"year":2008,"finding":"TMPRSS6 interacts physically with HJV through its ectodomain; the MASK mutant (lacking protease domain) retains this interaction but loses cleavage activity, demonstrating that binding and proteolysis are separable functions.","method":"Co-immunoprecipitation, domain-deletion analysis, cell-based cleavage assay","journal":"Cell metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP binding data combined with functional cleavage assay, single lab","pmids":["18976966"],"is_preprint":false},{"year":2010,"finding":"Tmprss6 down-regulates BMP/SMAD signaling in the liver; mice deficient for both Tmprss6 and hemojuvelin (Hjv) exhibit iron overload similar to Hjv-single-knockout mice with markedly reduced hepcidin and Id1 mRNA, placing Tmprss6 activity upstream of HJV in the BMP/SMAD pathway.","method":"Genetic epistasis (double-knockout mice), hepatic mRNA analysis (Id1, hepcidin), iron phenotyping","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic epistasis in vivo with double-KO rescue experiment and molecular readout","pmids":["20200349"],"is_preprint":false},{"year":2009,"finding":"IRIDA-associated missense mutations in the LDLRA domains of TMPRSS6 impair membrane targeting (causing Golgi retention) and abolish the autocatalytic activation cleavage required for protease activity, while a CUB domain mutation reduces but does not eliminate activation cleavage; all three mutants fail to fully repress hepcidin.","method":"cDNA transfection, subcellular localization (Golgi vs. plasma membrane), autocatalytic cleavage assay, hepcidin promoter reporter assay","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple orthogonal methods (localization, cleavage assay, promoter assay) in a single focused study","pmids":["19357398"],"is_preprint":false},{"year":2010,"finding":"A Y141C mutation in the SEA domain of TMPRSS6 prevents autocatalytic self-activation of the protease while preserving membrane localization and HJV binding, demonstrating that SEA domain integrity is required for TMPRSS6 proteolytic activation.","method":"Site-directed mutagenesis, cell transfection, subcellular localization, HJV-binding assay, autocatalytic cleavage assay, hepcidin mRNA measurement","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution-level mutagenesis with multiple orthogonal functional readouts in a single study","pmids":["20704562"],"is_preprint":false},{"year":2011,"finding":"TMPRSS6 undergoes constitutive clathrin/AP-2-dependent, dynamin-dependent endocytosis in hepatocytes; specific residues in its N-terminal cytoplasmic domain are required for internalization. Mutants locked at the cell surface show sustained HJV cleavage and produce significantly less hepcidin, indicating that endocytic trafficking limits TMPRSS6 activity and is essential for normal iron homeostasis.","method":"Cell-surface labeling, clathrin/AP-2 co-localization, dynamin inhibition, site-directed mutagenesis of cytoplasmic tail, HJV cleavage assay, hepcidin measurement","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple orthogonal methods (localization, inhibitor, mutagenesis, functional assay) in one study","pmids":["21724843"],"is_preprint":false},{"year":2011,"finding":"TMPRSS6 expression is positively regulated by BMP6 via the SMAD pathway (with ID1 as key mediator) and by iron loading in vivo; treatment with neutralizing anti-BMP6 antibody blocks Tmprss6 mRNA induction. This creates a negative feedback loop limiting excessive hepcidin increases.","method":"In vitro BMP6 treatment of hepatic cell lines (mRNA and protein levels, activity assay), in vivo iron loading and BMP6 injection in mice, anti-BMP6 antibody neutralization, siRNA knockdown of ID1","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Moderate — orthogonal in vitro and in vivo experiments in a single lab with genetic/pharmacologic perturbation","pmids":["21622652"],"is_preprint":false},{"year":2010,"finding":"TMPRSS6 expression in hepatic cells is up-regulated by hypoxia via both HIF-1α and HIF-2α; HIF-dependent TMPRSS6 induction increases membrane HJV shedding and decreases hepcidin promoter responsiveness to BMP signaling.","method":"Hypoxia treatment of hepatic cell lines, HIF activator treatment, HIF1α/HIF2α overexpression, HJV shedding assay, hepcidin promoter reporter assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple HIF isoforms tested with functional readouts, single lab","pmids":["20966077"],"is_preprint":false},{"year":2012,"finding":"A functional hypoxia-responsive element (HRE) containing a HIF-1α binding site was identified in the TMPRSS6 promoter; mutation of this site abrogates HIF-1α-dependent induction of TMPRSS6 expression.","method":"TMPRSS6 promoter characterization, HRE mutagenesis, reporter assay, HIF-1α overexpression","journal":"Biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — direct promoter mutagenesis with functional reporter, single lab, single study","pmids":["22628316"],"is_preprint":false},{"year":2013,"finding":"Inflammation down-regulates TMPRSS6 expression in vitro and in vivo through decreased STAT5 phosphorylation (not via BMP/SMAD); STAT5 directly binds a response element in the Tmprss6 promoter and positively regulates its transcription.","method":"IL-6 treatment and LPS injection, STAT5 phosphorylation analysis, chromatin immunoprecipitation (STAT5 binding to Tmprss6 promoter), reporter assay, in vivo mouse experiments","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP plus in vivo and in vitro experiments with multiple readouts in a single study","pmids":["24376517"],"is_preprint":false},{"year":2015,"finding":"TMPRSS6 cleaves HJV at arginine residues 121 and 326 (in both full-length and heterodimeric HJV isoforms); mutagenesis of these arginines to alanine abolishes normal cleavage fragment release, while other arginines in the von Willebrand domain are insensitive, likely due to protein structure.","method":"Site-directed mutagenesis of HJV arginine residues, analysis of cleavage fragment patterns by western blot, co-expression with TMPRSS6, molecular dynamics simulation","journal":"Journal of cellular and molecular medicine","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — direct mutagenesis of substrate cleavage sites with biochemical readout and structural modeling, single lab","pmids":["25704252"],"is_preprint":false},{"year":2009,"finding":"Double-knockout mice lacking both hemojuvelin and the matriptase-2 protease domain exhibit low Hamp expression and systemic iron overload, confirming that hemojuvelin is the major substrate for matriptase-2/TMPRSS6 proteolytic activity in vivo.","method":"Genetic epistasis (double-knockout mice), hepatic Hamp mRNA, serum/liver iron measurement","journal":"British journal of haematology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis in vivo; double-KO fully rescues iron overload, providing in vivo substrate validation","pmids":["19751239"],"is_preprint":false},{"year":2011,"finding":"Tmprss6 loss in Hfe(-/-) mice increases BMP/SMAD signaling in an HFE-independent manner; conversely, genetic loss of Hfe does not modify hepcidin elevation or iron deficiency in Tmprss6(-/-) mice, placing TMPRSS6 and HFE in partially parallel pathways that converge on BMP/SMAD signaling.","method":"Genetic epistasis (single and double-knockout mice), hepatic hepcidin/Id1 mRNA, iron phenotyping","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean genetic epistasis experiments with molecular readout, single lab","pmids":["21355094"],"is_preprint":false},{"year":2011,"finding":"In vitro, the common TMPRSS6 V736A variant (rs855791 A allele) inhibits hepcidin more efficiently than the 736V form; in a genotyped population with normal iron stores, 736A homozygotes have significantly lower hepcidin and higher iron parameters, demonstrating that rs855791 is a functional variant modulating TMPRSS6 enzymatic activity.","method":"In vitro hepcidin promoter assay with V736A vs. V736V constructs, population-based serum hepcidin measurement stratified by genotype","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro functional assay plus human population data, single lab","pmids":["21873547"],"is_preprint":false},{"year":2011,"finding":"Liver hemojuvelin protein content is paradoxically decreased (not increased) in Tmprss6-deficient mice compared to wild-type, and hemojuvelin cleavage pattern is altered, providing in vivo evidence that TMPRSS6 interaction with HJV influences HJV protein stability/processing beyond simple shedding.","method":"Immunoblot of liver membrane fractions from Tmprss6(+/+) vs. Tmprss6(-/-) mice, phosphatidylinositol-specific phospholipase C treatment to confirm GPI anchoring, comparison with hemojuvelin-mutant negative controls","journal":"Blood cells, molecules & diseases","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — careful biochemical fractionation in vivo, single lab, somewhat counterintuitive result without full mechanistic resolution","pmids":["21612955"],"is_preprint":false},{"year":2016,"finding":"Liver TMPRSS6 protein content is regulated post-transcriptionally: iron-deficient diet and erythropoietin treatment increase TMPRSS6 protein in rats and mice, while high doses of iron decrease it; intact hemojuvelin is required for stable TMPRSS6 membrane expression, as hemojuvelin-mutant mice show strongly decreased liver TMPRSS6 protein.","method":"Immunoblot of plasma membrane-enriched liver fractions, iron/EPO dosing in rodents, hemojuvelin-mutant mice comparison","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple conditions tested in vivo with biochemical readout, single lab","pmids":["26845567"],"is_preprint":false},{"year":2014,"finding":"Loss of hepatic TFR2 in Tmprss6(-/-) mice does not change the iron-deficiency anemia phenotype (unlike total Tfr2 loss), placing hepatic TFR2 upstream of TMPRSS6 in the hepcidin regulatory pathway. Loss of erythroid TFR2 in Tmprss6(-/-) mice causes relative erythrocytosis, revealing a separate erythroid role for TFR2 independent of TMPRSS6.","method":"Genetic epistasis (Tmprss6(-/-)Tfr2(-/-) and Tmprss6(-/-)Tfr2(LCKO) double-knockout mice), hepcidin expression, red cell and iron parameters","journal":"Haematologica","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean genetic epistasis with liver-specific vs. total Tfr2 deletion, multiple molecular readouts, single lab","pmids":["24658816"],"is_preprint":false},{"year":2018,"finding":"TMPRSS6 isoforms 3 and 4 (catalytically impaired) reduce the proteolytic activity of the main isoform 2 and behave as dominant negatives; TMPRSS6 also cleaves transferrin receptor 1 (TfR1) from the cell surface, identifying TfR1 as an additional substrate.","method":"Co-expression assays in hepatic cell lines, protease activity measurement, co-immunoprecipitation to detect isoform interactions, cell-surface TfR1 shedding assay","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct biochemical assays and shedding assay, single lab, single study","pmids":["36044454"],"is_preprint":false},{"year":2018,"finding":"TMPRSS6 isoforms 1–4 all reach the cell surface, but only isoform 1 undergoes internalization; truncated isoform 3 and catalytically impaired isoform 4 interact with HJV and prevent its cleavage by isoform 2, acting as dominant-negative regulators.","method":"Heterologous expression in HEK293 and Hep3B cells, cell-surface trafficking assay, HJV cleavage assay, isoform interaction studies","journal":"Journal of cellular and molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — functional cell-based assays with multiple isoforms, single lab","pmids":["29441715"],"is_preprint":false},{"year":2019,"finding":"Small-molecule peptidomimetic and non-peptidic inhibitors of TMPRSS6 proteolytic activity block TMPRSS6-dependent hemojuvelin cleavage and increase HAMP expression and secreted hepcidin in HepG2 cells and human primary hepatocytes.","method":"In vitro protease inhibition assay, HJV cleavage assay in hepatic cell lines and primary human hepatocytes, HAMP mRNA and secreted hepcidin measurement","journal":"Cell chemical biology","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — direct enzymatic inhibition confirmed in primary human hepatocytes with substrate cleavage and downstream hepcidin readout","pmids":["31543462"],"is_preprint":false},{"year":2024,"finding":"FKBP12 downregulation in hepatocytes (by antisense oligonucleotide) up-regulates Tmprss6 expression, thereby counteracting ALK2-mediated BMP/SMAD activation and buffering hepcidin induction; combined downregulation of both Fkbp12 and Tmprss6 blocks this compensatory mechanism, revealing a functional crosstalk between FKBP12 and TMPRSS6 in hepcidin regulation.","method":"Antisense oligonucleotide knockdown in vivo, hepcidin and Tmprss6 mRNA measurement, BMP/SMAD signaling readout (SMAD phosphorylation, target genes)","journal":"American journal of physiology. Gastrointestinal and liver physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — in vivo ASO knockdown with molecular readouts, single lab, single study","pmids":["38252872"],"is_preprint":false},{"year":2025,"finding":"TMPRSS6 down-regulation in the liver (via GalNAc-ASO) activates BMP-SMAD signaling and enhances PPARα transcriptional activity, reducing hepatosteatosis, inflammation, and fibrosis in experimental MASLD mice; TMPRSS6 expression in human MASLD livers negatively correlates with PPARα signaling, uncovering a novel TMPRSS6–PPARα functional crosstalk.","method":"GalNAc-ASO knockdown in MASLD mouse model, transcriptome analysis, BMP-SMAD and PPARα pathway readouts, human liver expression correlation","journal":"Liver international","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — in vivo ASO intervention with transcriptome profiling and pathway readouts, single lab, single study","pmids":["40501083"],"is_preprint":false},{"year":2014,"finding":"Matriptase-2 is expressed in the mouse retina, localized to the apical membrane of the retinal pigment epithelium (RPE) where its substrate hemojuvelin is also present; Tmprss6(msk/msk) knockout retinas are iron-deficient with upregulated hepcidin, and this retinal hepcidin upregulation occurs via IL-6/STAT3 signaling rather than BMP/SMAD signaling.","method":"RT-PCR, qPCR, immunofluorescence with apical/basolateral membrane markers, iron status markers (ferritin, TfR1), SMAD1/5/8 and STAT3 phosphorylation in Tmprss6(msk/msk) retinas","journal":"Molecular vision","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — multiple orthogonal assays in a single tissue/model, single lab","pmids":["24791141"],"is_preprint":false},{"year":2025,"finding":"A human monoclonal antibody (REGN7999) that inhibits TMPRSS6 reduced liver iron, ineffective erythropoiesis, and improved RBC health in an Hbbth3/+ β-thalassemia mouse model; in a phase 1 human trial, REGN7999 increased serum hepcidin and reduced serum iron with acceptable tolerability, confirming the mechanistic role of TMPRSS6 inhibition in elevating hepcidin in vivo.","method":"Anti-TMPRSS6 mAb treatment in mouse β-thalassemia model (iron, erythropoiesis, bone density readouts) and phase 1 randomized controlled trial in healthy humans (pharmacodynamic readouts)","journal":"JCI insight","confidence":"High","confidence_rationale":"Tier 2 / Moderate — validated in mouse disease model plus human phase 1 clinical pharmacodynamics with mechanistic endpoint","pmids":["40548380"],"is_preprint":false},{"year":2005,"finding":"TMPRSS6 encodes a type II transmembrane serine protease with a transmembrane domain, LDLRA domain, SRCR domain, and serine protease domain; it has substrate specificity slightly different from other TMPRSS family members and is strongly expressed in the thyroid.","method":"Molecular cloning, sequence analysis, expression profiling, substrate specificity assay","journal":"Molecules and cells","confidence":"Medium","confidence_rationale":"Tier 3 / Weak — initial biochemical characterization of domain structure and expression, single lab","pmids":["15879706"],"is_preprint":false}],"current_model":"TMPRSS6 (matriptase-2) is a liver-expressed type II transmembrane serine protease that down-regulates hepcidin transcription by cleaving the BMP co-receptor hemojuvelin (at Arg121 and Arg326) from the hepatocyte surface, thereby suppressing BMP/SMAD signaling; its activity is tightly controlled by autocatalytic activation (requiring an intact SEA domain), constitutive clathrin-dependent endocytic removal from the plasma membrane, transcriptional induction by BMP6/iron (via SMAD/ID1) and HIF-1/2 under hypoxia, transcriptional repression by inflammation via decreased STAT5 phosphorylation, and dominant-negative regulation by catalytically impaired splice isoforms, with loss-of-function causing IRIDA and gain of TMPRSS6 suppression (by ASO, siRNA, or antibody) raising hepcidin and ameliorating iron overload and ineffective erythropoiesis in thalassemia and hemochromatosis models."},"narrative":{"mechanistic_narrative":"TMPRSS6 (matriptase-2) is a liver-expressed type II transmembrane serine protease that serves as the principal negative regulator of the iron-regulatory hormone hepcidin, and its loss of function causes iron-refractory iron deficiency anemia (IRIDA) with inappropriately elevated hepcidin [PMID:18408718, PMID:18451267, PMID:18523150, PMID:18603562]. Mechanistically, TMPRSS6 cleaves the BMP co-receptor hemojuvelin (HJV) from the hepatocyte surface—at arginine residues 121 and 326—thereby damping BMP/SMAD signaling and lowering hepcidin transcription; the serine protease domain is required, and binding to HJV is separable from cleavage [PMID:18976966, PMID:25704252]. In vivo genetic epistasis establishes that TMPRSS6 acts upstream of HJV in the BMP/SMAD/ID1 pathway, with HJV being its major physiological substrate, and that it converges on BMP/SMAD in parallel with, and downstream of, HFE and hepatic TFR2 [PMID:20200349, PMID:19751239, PMID:21355094, PMID:24658816]. TMPRSS6 activity is tightly constrained: it requires autocatalytic self-activation that depends on intact SEA and LDLRA domains, and IRIDA mutations in these domains block activation or membrane targeting and fail to repress hepcidin [PMID:19357398, PMID:20704562]; constitutive clathrin/AP-2- and dynamin-dependent endocytosis via the cytoplasmic tail limits surface activity, since surface-locked mutants over-cleave HJV and suppress hepcidin excessively [PMID:21724843]. Transcription is induced by BMP6/iron through SMAD/ID1 as a negative feedback loop and by hypoxia through HIF-1α/HIF-2α acting at a promoter HRE, while inflammation represses it through reduced STAT5 phosphorylation [PMID:21622652, PMID:20966077, PMID:22628316, PMID:24376517]. Pharmacological suppression of TMPRSS6—by small-molecule protease inhibitors or an inhibitory monoclonal antibody—raises hepcidin, lowers serum and liver iron, and improves ineffective erythropoiesis in β-thalassemia models and in human phase 1 testing, validating it as a therapeutic target [PMID:31543462, PMID:40548380].","teleology":[{"year":2008,"claim":"Established TMPRSS6 as a physiological negative regulator of hepcidin, answering why its deficiency produces iron-deficiency anemia.","evidence":"Human germline mutation identification, Tmprss6-deficient mouse phenotyping, and hepcidin promoter assays","pmids":["18408718","18451267","18523150","18603562"],"confidence":"High","gaps":["Did not define the direct molecular substrate","Did not resolve how the protease lowers hepcidin transcription"]},{"year":2008,"claim":"Identified the direct molecular mechanism—cleavage of membrane HJV—and showed protease-dependent suppression of BMP/SMAD signaling, while distinguishing binding from proteolysis.","evidence":"Cell-based HJV cleavage and co-IP assays, domain-deletion (MASK) analysis, zebrafish overexpression","pmids":["18976966"],"confidence":"High","gaps":["Exact cleavage sites on HJV not yet mapped","Binding interface on HJV undefined"]},{"year":2009,"claim":"Defined how IRIDA mutations disable the enzyme, localizing activation control to the LDLRA (membrane targeting and autocatalysis) and CUB domains.","evidence":"cDNA transfection with subcellular localization, autocatalytic cleavage, and hepcidin reporter assays","pmids":["19357398"],"confidence":"High","gaps":["Structural basis of LDLRA-dependent trafficking not resolved","Activating protease/protease(s) for autocatalysis not identified"]},{"year":2009,"claim":"Confirmed in vivo that HJV is the major substrate by genetic epistasis, since double knockout recapitulates HJV-loss iron overload.","evidence":"Tmprss6/Hjv double-knockout mice with hepatic Hamp mRNA and iron measurement","pmids":["19751239"],"confidence":"High","gaps":["Does not exclude additional minor substrates","Quantitative contribution of HJV cleavage vs. stability changes unclear"]},{"year":2010,"claim":"Placed TMPRSS6 upstream of HJV within the BMP/SMAD/ID1 axis through clean epistasis.","evidence":"Tmprss6/Hjv double-knockout mice, hepatic Id1 and hepcidin mRNA","pmids":["20200349"],"confidence":"High","gaps":["Did not address parallel inputs (HFE, TFR2)"]},{"year":2010,"claim":"Showed SEA domain integrity is required for autocatalytic self-activation, separating activation from membrane localization and substrate binding.","evidence":"Y141C site-directed mutagenesis with localization, HJV binding, autocatalytic cleavage, and hepcidin readouts","pmids":["20704562"],"confidence":"High","gaps":["Trigger of autocatalysis under physiological conditions unknown"]},{"year":2010,"claim":"Revealed hypoxia as a transcriptional input, linking oxygen sensing to TMPRSS6-mediated hepcidin suppression via HIF-1α/HIF-2α.","evidence":"Hypoxia and HIF activator treatment, HIF overexpression, HJV shedding and hepcidin reporter assays","pmids":["20966077"],"confidence":"Medium","gaps":["Promoter element not yet localized in this study","Relative roles of HIF-1α vs HIF-2α in vivo unclear"]},{"year":2011,"claim":"Mapped the BMP6/iron feedback loop, showing TMPRSS6 is itself a SMAD/ID1 target that limits excessive hepcidin.","evidence":"BMP6 and iron treatment in vitro and in vivo, anti-BMP6 neutralization, ID1 siRNA","pmids":["21622652"],"confidence":"High","gaps":["Direct SMAD/ID1 binding to the Tmprss6 promoter not delineated here"]},{"year":2011,"claim":"Identified constitutive clathrin/AP-2/dynamin-dependent endocytosis as a brake on surface protease activity essential for iron homeostasis.","evidence":"Cell-surface labeling, clathrin/AP-2 co-localization, dynamin inhibition, cytoplasmic-tail mutagenesis, HJV cleavage and hepcidin assays","pmids":["21724843"],"confidence":"High","gaps":["Post-endocytic fate (recycling vs degradation) not defined","Regulation of internalization rate by iron status not established"]},{"year":2011,"claim":"Resolved that TMPRSS6 and HFE act in partially parallel pathways converging on BMP/SMAD, clarifying genetic interactions.","evidence":"Single and double Hfe/Tmprss6 knockout mice with hepcidin/Id1 mRNA and iron phenotyping","pmids":["21355094"],"confidence":"High","gaps":["Molecular point of convergence on BMP/SMAD undefined"]},{"year":2011,"claim":"Showed the common V736A variant (rs855791) is a functional modifier of TMPRSS6 enzymatic efficiency, linking genotype to human iron parameters.","evidence":"In vitro hepcidin reporter assay with V736A vs V736V, genotype-stratified population hepcidin data","pmids":["21873547"],"confidence":"Medium","gaps":["Structural basis of altered activity unresolved","Effect size in disease populations not addressed"]},{"year":2011,"claim":"Revealed an unexpected reciprocal dependence: HJV protein content and processing are altered in TMPRSS6-deficient liver, implying TMPRSS6 influences HJV stability beyond shedding.","evidence":"Immunoblot of liver membrane fractions with PI-PLC treatment and HJV-mutant controls","pmids":["21612955"],"confidence":"Medium","gaps":["Mechanism of paradoxical HJV decrease not resolved","Counterintuitive result without full mechanistic explanation"]},{"year":2012,"claim":"Localized the functional HRE in the TMPRSS6 promoter, confirming direct HIF-1α-dependent transcriptional control.","evidence":"Promoter HRE mutagenesis with reporter assay and HIF-1α overexpression","pmids":["22628316"],"confidence":"Medium","gaps":["In vivo occupancy of the HRE not demonstrated","Single study, single lab"]},{"year":2013,"claim":"Defined the inflammatory repression pathway, showing TMPRSS6 is positively regulated by STAT5 and downregulated when STAT5 phosphorylation falls during inflammation.","evidence":"IL-6/LPS treatment, STAT5 phosphorylation analysis, ChIP for STAT5 on Tmprss6 promoter, reporter and in vivo experiments","pmids":["24376517"],"confidence":"High","gaps":["Upstream signal coupling inflammation to STAT5 dephosphorylation not detailed"]},{"year":2014,"claim":"Positioned hepatic TFR2 upstream of TMPRSS6 and uncovered a separate erythroid TFR2 role, refining the pathway hierarchy.","evidence":"Tmprss6/Tfr2 and Tmprss6/Tfr2(LCKO) double-knockout mice with hepcidin and red-cell parameters","pmids":["24658816"],"confidence":"High","gaps":["Biochemical interaction between TFR2 and TMPRSS6 not shown"]},{"year":2014,"claim":"Extended TMPRSS6/HJV function beyond liver to the retinal pigment epithelium, where hepcidin regulation uses IL-6/STAT3 rather than BMP/SMAD.","evidence":"RT-PCR/qPCR, immunofluorescence with membrane markers, iron and signaling readouts in Tmprss6(msk/msk) retinas","pmids":["24791141"],"confidence":"Medium","gaps":["Physiological importance of retinal TMPRSS6 unclear","Tissue-specific signaling switch mechanism unknown"]},{"year":2015,"claim":"Mapped the precise HJV cleavage sites (Arg121, Arg326), defining substrate specificity at residue resolution.","evidence":"Site-directed mutagenesis of HJV arginines, cleavage fragment analysis, molecular dynamics simulation","pmids":["25704252"],"confidence":"High","gaps":["Order/kinetics of dual cleavage not established","Structural enzyme-substrate complex not solved"]},{"year":2016,"claim":"Showed TMPRSS6 protein is regulated post-transcriptionally by iron and EPO and depends on intact HJV for stable membrane expression.","evidence":"Immunoblot of plasma-membrane liver fractions under iron/EPO dosing and in HJV-mutant mice","pmids":["26845567"],"confidence":"Medium","gaps":["Molecular basis of HJV-dependent TMPRSS6 stabilization unknown","Link to EPO signaling unresolved"]},{"year":2018,"claim":"Identified dominant-negative splice isoforms and a second substrate (TfR1), expanding the regulatory and substrate repertoire.","evidence":"Co-expression and protease activity assays, co-IP of isoform interactions, surface TfR1 and HJV shedding assays in hepatic and HEK293 cells","pmids":["36044454","29441715"],"confidence":"Medium","gaps":["Physiological relevance of TfR1 cleavage in vivo not shown","In vivo abundance and impact of isoforms 3/4 unquantified"]},{"year":2019,"claim":"Demonstrated druggability of the protease, with small-molecule inhibitors blocking HJV cleavage and raising hepcidin in primary human hepatocytes.","evidence":"In vitro protease inhibition, HJV cleavage assay, HAMP/hepcidin readouts in HepG2 and primary human hepatocytes","pmids":["31543462"],"confidence":"High","gaps":["In vivo efficacy and selectivity of these compounds not addressed in this study"]},{"year":2024,"claim":"Revealed FKBP12-TMPRSS6 crosstalk, where FKBP12 loss raises Tmprss6 to buffer ALK2-driven BMP/SMAD activation.","evidence":"In vivo ASO knockdown of Fkbp12 and Tmprss6 with hepcidin/Tmprss6 mRNA and SMAD signaling readouts","pmids":["38252872"],"confidence":"Medium","gaps":["Direct mechanism linking FKBP12 to Tmprss6 transcription unknown","Single study, single lab"]},{"year":2025,"claim":"Uncovered a TMPRSS6-PPARα axis, where hepatic TMPRSS6 suppression activates BMP-SMAD and PPARα to ameliorate steatohepatitis, broadening its role beyond iron homeostasis.","evidence":"GalNAc-ASO knockdown in MASLD mice with transcriptomics and pathway readouts, plus human liver expression correlation","pmids":["40501083"],"confidence":"Medium","gaps":["Mechanistic link between BMP-SMAD and PPARα not defined","Single study, single lab"]},{"year":2025,"claim":"Provided in vivo and human clinical validation of TMPRSS6 inhibition as a hepcidin-raising therapy for iron-loading anemia.","evidence":"Anti-TMPRSS6 mAb (REGN7999) in Hbbth3/+ β-thalassemia mice and a phase 1 randomized trial with pharmacodynamic endpoints","pmids":["40548380"],"confidence":"High","gaps":["Long-term efficacy and clinical outcomes in patients not yet established"]},{"year":null,"claim":"How TMPRSS6 surface activity is dynamically tuned by iron and erythropoietic signals—integrating autocatalytic activation, endocytic turnover, HJV-dependent stability, and isoform dominant-negative effects into a single quantitative control model—remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of the active enzyme-HJV complex","Physiological trigger of autocatalytic activation undefined","In vivo significance of TfR1 cleavage and splice isoforms unquantified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[1,4,5,11,18,20]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[1,11,25]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3,7]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,6,16,25]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[4]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,3,12]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,7,13]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[7,9,10]}],"complexes":[],"partners":["HJV","TFR1","FKBP12"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q8IU80","full_name":"Transmembrane protease serine 6","aliases":["Matriptase-2"],"length_aa":811,"mass_kda":90.0,"function":"Membrane-bound serine protease (PubMed:18976966, PubMed:20518742, PubMed:25156943, PubMed:25588876). Through the cleavage of cell surface hemojuvelin (HJV), a regulator of the expression of the iron absorption-regulating hormone hepicidin/HAMP, plays a role in iron homeostasis (PubMed:18408718, PubMed:18976966, PubMed:25156943)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q8IU80/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TMPRSS6","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TMPRSS6","total_profiled":1310},"omim":[{"mim_id":"614193","title":"TRANSFERRIN SERUM LEVEL QUANTITATIVE TRAIT LOCUS 2; TFQTL2","url":"https://www.omim.org/entry/614193"},{"mim_id":"613284","title":"HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3; HCHGQ3","url":"https://www.omim.org/entry/613284"},{"mim_id":"610560","title":"PROTEASE, SERINE, 36; PRSS36","url":"https://www.omim.org/entry/610560"},{"mim_id":"610477","title":"TRANSMEMBRANE PROTEASE, SERINE 9; TMPRSS9","url":"https://www.omim.org/entry/610477"},{"mim_id":"609862","title":"TRANSMEMBRANE PROTEASE, SERINE 6; TMPRSS6","url":"https://www.omim.org/entry/609862"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"liver","ntpm":129.5}],"url":"https://www.proteinatlas.org/search/TMPRSS6"},"hgnc":{"alias_symbol":["FLJ30744","MT2"],"prev_symbol":[]},"alphafold":{"accession":"Q8IU80","domains":[{"cath_id":"3.30.70.960","chopping":"84-208","consensus_level":"medium","plddt":87.0838,"start":84,"end":208},{"cath_id":"2.60.120.290","chopping":"213-331","consensus_level":"medium","plddt":87.9065,"start":213,"end":331},{"cath_id":"2.60.120.290","chopping":"338-458","consensus_level":"high","plddt":91.2049,"start":338,"end":458},{"cath_id":"2.40.10.10","chopping":"582-811","consensus_level":"medium","plddt":91.3673,"start":582,"end":811}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8IU80","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8IU80-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8IU80-F1-predicted_aligned_error_v6.png","plddt_mean":84.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TMPRSS6","jax_strain_url":"https://www.jax.org/strain/search?query=TMPRSS6"},"sequence":{"accession":"Q8IU80","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8IU80.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8IU80/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8IU80"}},"corpus_meta":[{"pmid":"18408718","id":"PMC_18408718","title":"Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA).","date":"2008","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18408718","citation_count":505,"is_preprint":false},{"pmid":"18451267","id":"PMC_18451267","title":"The serine protease TMPRSS6 is required to sense iron deficiency.","date":"2008","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/18451267","citation_count":463,"is_preprint":false},{"pmid":"18976966","id":"PMC_18976966","title":"The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin.","date":"2008","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/18976966","citation_count":438,"is_preprint":false},{"pmid":"18523150","id":"PMC_18523150","title":"Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis.","date":"2008","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/18523150","citation_count":248,"is_preprint":false},{"pmid":"19820699","id":"PMC_19820699","title":"Common variants in TMPRSS6 are associated with iron status and erythrocyte volume.","date":"2009","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19820699","citation_count":202,"is_preprint":false},{"pmid":"23524968","id":"PMC_23524968","title":"Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice.","date":"2013","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/23524968","citation_count":195,"is_preprint":false},{"pmid":"23223430","id":"PMC_23223430","title":"An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.","date":"2012","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/23223430","citation_count":173,"is_preprint":false},{"pmid":"18603562","id":"PMC_18603562","title":"A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron.","date":"2008","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/18603562","citation_count":143,"is_preprint":false},{"pmid":"22490684","id":"PMC_22490684","title":"Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia.","date":"2012","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/22490684","citation_count":137,"is_preprint":false},{"pmid":"20200349","id":"PMC_20200349","title":"Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/20200349","citation_count":125,"is_preprint":false},{"pmid":"19357398","id":"PMC_19357398","title":"Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia.","date":"2009","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19357398","citation_count":97,"is_preprint":false},{"pmid":"19377077","id":"PMC_19377077","title":"Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis.","date":"2009","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/19377077","citation_count":96,"is_preprint":false},{"pmid":"21622652","id":"PMC_21622652","title":"Regulation of TMPRSS6 by BMP6 and iron in human cells and mice.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21622652","citation_count":94,"is_preprint":false},{"pmid":"18596229","id":"PMC_18596229","title":"Two nonsense mutations in the TMPRSS6 gene in a patient with microcytic anemia and iron deficiency.","date":"2008","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/18596229","citation_count":93,"is_preprint":false},{"pmid":"21873547","id":"PMC_21873547","title":"TMPRSS6 rs855791 modulates hepcidin transcription in vitro and serum hepcidin levels in normal individuals.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21873547","citation_count":92,"is_preprint":false},{"pmid":"20966077","id":"PMC_20966077","title":"Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia-inducible factors: new link between hypoxia signaling and iron homeostasis.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20966077","citation_count":89,"is_preprint":false},{"pmid":"21785125","id":"PMC_21785125","title":"Association of HFE and TMPRSS6 genetic variants with iron and erythrocyte parameters is only in part dependent on serum hepcidin concentrations.","date":"2011","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21785125","citation_count":81,"is_preprint":false},{"pmid":"21355094","id":"PMC_21355094","title":"Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21355094","citation_count":75,"is_preprint":false},{"pmid":"20232450","id":"PMC_20232450","title":"Novel TMPRSS6 mutations associated with iron-refractory iron deficiency anemia (IRIDA).","date":"2010","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/20232450","citation_count":57,"is_preprint":false},{"pmid":"24966834","id":"PMC_24966834","title":"The role of TMPRSS6/matriptase-2 in iron regulation and anemia.","date":"2014","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24966834","citation_count":55,"is_preprint":false},{"pmid":"19818657","id":"PMC_19818657","title":"Polymorphisms and mutations of human TMPRSS6 in iron deficiency anemia.","date":"2009","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/19818657","citation_count":53,"is_preprint":false},{"pmid":"22301935","id":"PMC_22301935","title":"Association of TMPRSS6 polymorphisms with ferritin, hemoglobin, and type 2 diabetes risk in a Chinese Han population.","date":"2012","source":"The American journal of clinical nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/22301935","citation_count":53,"is_preprint":false},{"pmid":"19751239","id":"PMC_19751239","title":"Suppression of the hepcidin-encoding gene Hamp permits iron overload in mice lacking both hemojuvelin and matriptase-2/TMPRSS6.","date":"2009","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/19751239","citation_count":52,"is_preprint":false},{"pmid":"25156943","id":"PMC_25156943","title":"Functional and clinical impact of novel TMPRSS6 variants in iron-refractory iron-deficiency anemia patients and genotype-phenotype studies.","date":"2014","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/25156943","citation_count":49,"is_preprint":false},{"pmid":"20704562","id":"PMC_20704562","title":"A novel TMPRSS6 mutation that prevents protease auto-activation causes IRIDA.","date":"2010","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/20704562","citation_count":37,"is_preprint":false},{"pmid":"22628316","id":"PMC_22628316","title":"Matriptase-2 (TMPRSS6) is directly up-regulated by hypoxia inducible factor-1: identification of a hypoxia-responsive element in the TMPRSS6 promoter region.","date":"2012","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22628316","citation_count":37,"is_preprint":false},{"pmid":"16533768","id":"PMC_16533768","title":"Refinement of the 22q12-q13 breast cancer--associated region: evidence of TMPRSS6 as a candidate gene in an eastern Finnish population.","date":"2006","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/16533768","citation_count":36,"is_preprint":false},{"pmid":"33835366","id":"PMC_33835366","title":"IL-6 Regulates Hepcidin Expression Via the BMP/SMAD Pathway by Altering BMP6, TMPRSS6 and TfR2 Expressions at Normal and Inflammatory Conditions in BV2 Microglia.","date":"2021","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/33835366","citation_count":35,"is_preprint":false},{"pmid":"24658816","id":"PMC_24658816","title":"The erythroid function of transferrin receptor 2 revealed by Tmprss6 inactivation in different models of transferrin receptor 2 knockout mice.","date":"2014","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/24658816","citation_count":34,"is_preprint":false},{"pmid":"20738301","id":"PMC_20738301","title":"Genetic variability of TMPRSS6 and its association with iron deficiency anaemia.","date":"2010","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/20738301","citation_count":32,"is_preprint":false},{"pmid":"25557470","id":"PMC_25557470","title":"The role of TMPRSS6 polymorphisms in iron deficiency anemia partially responsive to oral iron treatment.","date":"2015","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/25557470","citation_count":31,"is_preprint":false},{"pmid":"25416640","id":"PMC_25416640","title":"Inter-ethnic differences in genetic variants within the transmembrane protease, serine 6 (TMPRSS6) gene associated with iron status indicators: a systematic review with meta-analyses.","date":"2014","source":"Genes & nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/25416640","citation_count":31,"is_preprint":false},{"pmid":"36690839","id":"PMC_36690839","title":"TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis.","date":"2023","source":"Advances in therapy","url":"https://pubmed.ncbi.nlm.nih.gov/36690839","citation_count":29,"is_preprint":false},{"pmid":"19907145","id":"PMC_19907145","title":"Role of matriptase-2 (TMPRSS6) in iron metabolism.","date":"2009","source":"Acta haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/19907145","citation_count":29,"is_preprint":false},{"pmid":"22885719","id":"PMC_22885719","title":"Effect of the A736V TMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosis.","date":"2012","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/22885719","citation_count":29,"is_preprint":false},{"pmid":"31543462","id":"PMC_31543462","title":"Discovery and Development of TMPRSS6 Inhibitors Modulating Hepcidin Levels in Human Hepatocytes.","date":"2019","source":"Cell chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/31543462","citation_count":28,"is_preprint":false},{"pmid":"22244935","id":"PMC_22244935","title":"Severe microcytic anemia but increased erythropoiesis in mice lacking Hfe or Tfr2 and Tmprss6.","date":"2012","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/22244935","citation_count":26,"is_preprint":false},{"pmid":"29194702","id":"PMC_29194702","title":"The role of TMPRSS6 and HFE variants in iron deficiency anemia in celiac disease.","date":"2017","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/29194702","citation_count":25,"is_preprint":false},{"pmid":"21612955","id":"PMC_21612955","title":"Liver hemojuvelin protein levels in mice deficient in matriptase-2 (Tmprss6).","date":"2011","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/21612955","citation_count":24,"is_preprint":false},{"pmid":"24782651","id":"PMC_24782651","title":"TMPRSS6 rs855791 polymorphism influences the susceptibility to iron deficiency anemia in women at reproductive age.","date":"2014","source":"International journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/24782651","citation_count":24,"is_preprint":false},{"pmid":"21643693","id":"PMC_21643693","title":"Novel missense mutation in the TMPRSS6 gene in a Japanese female with iron-refractory iron deficiency anemia.","date":"2011","source":"International journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/21643693","citation_count":23,"is_preprint":false},{"pmid":"24376517","id":"PMC_24376517","title":"Inflammation regulates TMPRSS6 expression via STAT5.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24376517","citation_count":22,"is_preprint":false},{"pmid":"37497888","id":"PMC_37497888","title":"SLN124, a GalNAc conjugated 19-mer siRNA targeting tmprss6, reduces plasma iron and increases hepcidin levels of healthy volunteers.","date":"2023","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/37497888","citation_count":22,"is_preprint":false},{"pmid":"21724843","id":"PMC_21724843","title":"Essential role of endocytosis of the type II transmembrane serine protease TMPRSS6 in regulating its functionality.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21724843","citation_count":22,"is_preprint":false},{"pmid":"25704252","id":"PMC_25704252","title":"Identification of TMPRSS6 cleavage sites of hemojuvelin.","date":"2015","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25704252","citation_count":21,"is_preprint":false},{"pmid":"21618415","id":"PMC_21618415","title":"A novel mutation Gly603Arg of TMPRSS6 in a Korean female with iron-refractory iron deficiency anemia.","date":"2011","source":"Pediatric blood & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21618415","citation_count":21,"is_preprint":false},{"pmid":"23649491","id":"PMC_23649491","title":"Matriptase-2 gene (TMPRSS6) variants associate with breast cancer survival, and reduced expression is related to triple-negative breast cancer.","date":"2013","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/23649491","citation_count":20,"is_preprint":false},{"pmid":"23433094","id":"PMC_23433094","title":"The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis.","date":"2013","source":"BMC nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/23433094","citation_count":19,"is_preprint":false},{"pmid":"34890402","id":"PMC_34890402","title":"Tmprss6-ASO as a tool for the treatment of Polycythemia Vera mice.","date":"2021","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/34890402","citation_count":19,"is_preprint":false},{"pmid":"22265928","id":"PMC_22265928","title":"Common TMPRSS6 mutations and iron, erythrocyte, and pica phenotypes in 48 women with iron deficiency or depletion.","date":"2012","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/22265928","citation_count":18,"is_preprint":false},{"pmid":"26845567","id":"PMC_26845567","title":"Effect of Erythropoietin, Iron Deficiency and Iron Overload on Liver Matriptase-2 (TMPRSS6) Protein Content in Mice and Rats.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26845567","citation_count":18,"is_preprint":false},{"pmid":"29498084","id":"PMC_29498084","title":"RNAi-mediated reduction of hepatic Tmprss6 diminishes anemia and secondary iron overload in a splenectomized mouse model of β-thalassemia intermedia.","date":"2018","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/29498084","citation_count":17,"is_preprint":false},{"pmid":"28169443","id":"PMC_28169443","title":"Systematic evaluation of paediatric cohort with iron refractory iron deficiency anaemia (IRIDA) phenotype reveals multiple TMPRSS6 gene variations.","date":"2017","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/28169443","citation_count":17,"is_preprint":false},{"pmid":"25809685","id":"PMC_25809685","title":"Common Variants and Haplotypes in the TF, TNF-α, and TMPRSS6 Genes Are Associated with Iron Status in a Female Black South African Population.","date":"2015","source":"The Journal of nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/25809685","citation_count":16,"is_preprint":false},{"pmid":"15879706","id":"PMC_15879706","title":"Cloning and characterization of TMPRSS6, a novel type 2 transmembrane serine protease.","date":"2005","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/15879706","citation_count":16,"is_preprint":false},{"pmid":"22509377","id":"PMC_22509377","title":"Candidate gene sequencing of SLC11A2 and TMPRSS6 in a family with severe anaemia: common SNPs, rare haplotypes, no causative mutation.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22509377","citation_count":16,"is_preprint":false},{"pmid":"30885835","id":"PMC_30885835","title":"Natural selection on TMPRSS6 associated with the blunted erythropoiesis and improved blood viscosity in Tibetan pigs.","date":"2019","source":"Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/30885835","citation_count":15,"is_preprint":false},{"pmid":"28447549","id":"PMC_28447549","title":"A child with severe iron-deficiency anemia and a complex TMPRSS6 genotype.","date":"2017","source":"Hematology (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/28447549","citation_count":15,"is_preprint":false},{"pmid":"28460265","id":"PMC_28460265","title":"Two novel mutations in TMPRSS6 associated with iron-refractory iron deficiency anemia in a mother and child.","date":"2017","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/28460265","citation_count":14,"is_preprint":false},{"pmid":"25252070","id":"PMC_25252070","title":"Novel mutation in the TMPRSS6 gene with iron-refractory iron deficiency anemia.","date":"2014","source":"Pediatrics international : official journal of the Japan Pediatric Society","url":"https://pubmed.ncbi.nlm.nih.gov/25252070","citation_count":13,"is_preprint":false},{"pmid":"27120435","id":"PMC_27120435","title":"Iron-refractory iron deficiency anemia (IRIDA) cases with 2 novel TMPRSS6 mutations.","date":"2016","source":"Pediatric hematology and oncology","url":"https://pubmed.ncbi.nlm.nih.gov/27120435","citation_count":13,"is_preprint":false},{"pmid":"24382527","id":"PMC_24382527","title":"Is the acronym IRIDA acceptable for slow responders to iron in the presence of TMPRSS6 mutations?","date":"2013","source":"The Turkish journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/24382527","citation_count":13,"is_preprint":false},{"pmid":"30135444","id":"PMC_30135444","title":"Functional diversity of TMPRSS6 isoforms and variants expressed in hepatocellular carcinoma cell lines.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30135444","citation_count":12,"is_preprint":false},{"pmid":"29441715","id":"PMC_29441715","title":"Transcriptome analysis reveals TMPRSS6 isoforms with distinct functionalities.","date":"2018","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29441715","citation_count":11,"is_preprint":false},{"pmid":"33054130","id":"PMC_33054130","title":"The <em>TMPRSS6</em> variant (SNP rs855791) affects iron metabolism and oral iron absorption - a stable iron isotope study in Taiwanese women.","date":"2021","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/33054130","citation_count":11,"is_preprint":false},{"pmid":"28282554","id":"PMC_28282554","title":"Erythropoietin administration increases splenic erythroferrone protein content and liver TMPRSS6 protein content in rats.","date":"2017","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/28282554","citation_count":10,"is_preprint":false},{"pmid":"35163840","id":"PMC_35163840","title":"Transferrin Saturation/Hepcidin Ratio Discriminates TMPRSS6-Related Iron Refractory Iron Deficiency Anemia from Patients with Multi-Causal Iron Deficiency Anemia.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35163840","citation_count":10,"is_preprint":false},{"pmid":"24791141","id":"PMC_24791141","title":"Retinal expression of the serine protease matriptase-2 (Tmprss6) and its role in retinal iron homeostasis.","date":"2014","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/24791141","citation_count":9,"is_preprint":false},{"pmid":"33850216","id":"PMC_33850216","title":"Association of common TMPRSS6 and TF gene variants with hepcidin and iron status in healthy rural Gambians.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33850216","citation_count":9,"is_preprint":false},{"pmid":"29073189","id":"PMC_29073189","title":"Effect of erythropoietin administration on proteins participating in iron homeostasis in Tmprss6-mutated mask mice.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29073189","citation_count":9,"is_preprint":false},{"pmid":"32363518","id":"PMC_32363518","title":"Associations of TMPRSS6 Polymorphisms with Gestational Diabetes Mellitus in Chinese Han Pregnant Women: a Preliminary Cohort Study.","date":"2020","source":"Biological trace element research","url":"https://pubmed.ncbi.nlm.nih.gov/32363518","citation_count":9,"is_preprint":false},{"pmid":"32446932","id":"PMC_32446932","title":"Genetic analysis of TMPRSS6 gene in Saudi female patients with iron deficiency anemia.","date":"2020","source":"Hematology/oncology and stem cell therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32446932","citation_count":8,"is_preprint":false},{"pmid":"31010126","id":"PMC_31010126","title":"The Association of TMPRSS6 Gene Polymorphism and Iron Intake with Iron Status among Under-Two-Year-Old Children in Lombok, Indonesia.","date":"2019","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/31010126","citation_count":8,"is_preprint":false},{"pmid":"29928945","id":"PMC_29928945","title":"The role of TMPRSS6 gene variants in iron-related hematological parameters in Turkish patients with iron deficiency anemia.","date":"2018","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/29928945","citation_count":8,"is_preprint":false},{"pmid":"28491880","id":"PMC_28491880","title":"Iron Refractory Iron Deficiency Anemia in Dizygotic Twins Due to a Novel TMPRSS6 Gene Mutation in Addition to Polymorphisms Associated With High Susceptibility to Develop Ferropenic Anemia.","date":"2017","source":"Journal of investigative medicine high impact case reports","url":"https://pubmed.ncbi.nlm.nih.gov/28491880","citation_count":8,"is_preprint":false},{"pmid":"36295822","id":"PMC_36295822","title":"Associated Effect of SLC40A1 and TMPRSS6 Polymorphisms on Iron Overload.","date":"2022","source":"Metabolites","url":"https://pubmed.ncbi.nlm.nih.gov/36295822","citation_count":7,"is_preprint":false},{"pmid":"38659383","id":"PMC_38659383","title":"Combination of a TGF-β ligand trap (RAP-GRL) and TMPRSS6-ASO is superior for correcting β-thalassemia.","date":"2024","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/38659383","citation_count":7,"is_preprint":false},{"pmid":"23922777","id":"PMC_23922777","title":"A strong anti-inflammatory signature revealed by liver transcription profiling of Tmprss6-/- mice.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23922777","citation_count":7,"is_preprint":false},{"pmid":"38072851","id":"PMC_38072851","title":"The role of TMPRSS6 gene polymorphism in iron resistance iron deficiency anaemia (IRIDA): a systematic review.","date":"2023","source":"Annals of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/38072851","citation_count":6,"is_preprint":false},{"pmid":"23300183","id":"PMC_23300183","title":"Identification and characterization of a novel murine allele of Tmprss6.","date":"2013","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/23300183","citation_count":6,"is_preprint":false},{"pmid":"40501083","id":"PMC_40501083","title":"Targeting the Liver Serine Protease TMPRSS6 Ameliorates Steatosis and Attenuates Fibrosis in Experimental MASLD.","date":"2025","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/40501083","citation_count":5,"is_preprint":false},{"pmid":"34444942","id":"PMC_34444942","title":"TMPRSS6 rs855791 Polymorphism Status in Children with Celiac Disease and Anemia.","date":"2021","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/34444942","citation_count":5,"is_preprint":false},{"pmid":"33817543","id":"PMC_33817543","title":"Common Variants in the TMPRSS6 Gene Alter Hepcidin but not Plasma Iron in Response to Oral Iron in Healthy Gambian Adults: A Recall-by-Genotype Study.","date":"2021","source":"Current developments in nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/33817543","citation_count":5,"is_preprint":false},{"pmid":"33930800","id":"PMC_33930800","title":"A case series highlighting structured hematological, biochemical and molecular approach to clinical oral iron refractoriness in children: A pressing need for a 3-tier system for classification of variants in TMPRSS6 gene.","date":"2021","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/33930800","citation_count":5,"is_preprint":false},{"pmid":"38341535","id":"PMC_38341535","title":"The association of TMPRSS6 gene polymorphism with iron status in Egyptian children (a pilot study).","date":"2024","source":"BMC pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/38341535","citation_count":4,"is_preprint":false},{"pmid":"36261087","id":"PMC_36261087","title":"TMPRSS6 gene mutations in six Saudi families with iron refractory iron deficiency anemia.","date":"2022","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/36261087","citation_count":4,"is_preprint":false},{"pmid":"35893046","id":"PMC_35893046","title":"IRIDA Phenotype in TMPRSS6 Monoallelic-Affected Patients: Toward a Better Understanding of the Pathophysiology.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/35893046","citation_count":4,"is_preprint":false},{"pmid":"30130276","id":"PMC_30130276","title":"Iron Refractory Iron Deficiency Anemia Due to 374 Base Pairs Deletion in the TMPRSS6 Gene.","date":"2019","source":"Journal of pediatric hematology/oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30130276","citation_count":4,"is_preprint":false},{"pmid":"36044454","id":"PMC_36044454","title":"Functionally impaired isoforms regulate TMPRSS6 proteolytic activity.","date":"2022","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/36044454","citation_count":3,"is_preprint":false},{"pmid":"40081160","id":"PMC_40081160","title":"Lack of association between the TMPRSS6 gene polymorphism (rs855791) and anemia: a comprehensive meta-analysis.","date":"2025","source":"Hematology, transfusion and cell therapy","url":"https://pubmed.ncbi.nlm.nih.gov/40081160","citation_count":3,"is_preprint":false},{"pmid":"38252872","id":"PMC_38252872","title":"A functional interplay between the two BMP-SMAD pathway inhibitors TMPRSS6 and FKBP12 regulates hepcidin expression in vivo.","date":"2024","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/38252872","citation_count":3,"is_preprint":false},{"pmid":"21783390","id":"PMC_21783390","title":"Rapid, accurate detection of TMPRSS6 gene causative mutations with a high-resolution melting assay.","date":"2011","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/21783390","citation_count":3,"is_preprint":false},{"pmid":"33424363","id":"PMC_33424363","title":"Role of TMPRSS6 rs855791 (T > C) polymorphism in reproductive age women with iron deficiency anemia from Lahore, Pakistan.","date":"2020","source":"Saudi journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33424363","citation_count":3,"is_preprint":false},{"pmid":"32253873","id":"PMC_32253873","title":"A novel homozygous nonsense mutation (p.Y78*) in TMPRSS6 gene causing iron-refractory iron deficiency anemia (IRIDA) in two siblings.","date":"2020","source":"The Turkish journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/32253873","citation_count":3,"is_preprint":false},{"pmid":"40548380","id":"PMC_40548380","title":"A TMPRSS6-inhibiting mAb improves disease in a β-thalassemia mouse model and reduces iron in healthy humans.","date":"2025","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/40548380","citation_count":2,"is_preprint":false},{"pmid":"37006987","id":"PMC_37006987","title":"Genetic Variations of ferroportin-1(FPN1-8CG), TMPRSS6 (rs855791) and Hemojuvelin (I222N and G320V) Among a Cohort of Egyptian β-Thalassemia Major Patients.","date":"2022","source":"Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion","url":"https://pubmed.ncbi.nlm.nih.gov/37006987","citation_count":2,"is_preprint":false},{"pmid":"30111473","id":"PMC_30111473","title":"[Association of FokI rs2228570 and TMPRSS6 rs855791 polymorphisms with cow's milk protein allergy in children].","date":"2018","source":"Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/30111473","citation_count":2,"is_preprint":false},{"pmid":"36140670","id":"PMC_36140670","title":"Common Single Nucleotide Polymorphism of TMPRSS6, an Iron Regulation Gene, Associated with Variable Red Blood Cell Indices in Deletional α-Globin Genotypes.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/36140670","citation_count":2,"is_preprint":false},{"pmid":"40638821","id":"PMC_40638821","title":"Tmprss6 modulates radiation-induced liver injury through the hepcidin axis and PI3K/AKT pathway.","date":"2025","source":"International journal of radiation biology","url":"https://pubmed.ncbi.nlm.nih.gov/40638821","citation_count":1,"is_preprint":false},{"pmid":"37605822","id":"PMC_37605822","title":"Anaemia and iron deficiency associate with polymorphism TMPRSS6 rs855791 in Brazilian children attending day care centres.","date":"2023","source":"The British journal of nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/37605822","citation_count":1,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50732,"output_tokens":6319,"usd":0.123491,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15215,"output_tokens":6083,"usd":0.114075,"stage2_stop_reason":"end_turn"},"total_usd":0.237566,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2008,\n      \"finding\": \"TMPRSS6 (matriptase-2) is a liver-expressed type II transmembrane serine protease that negatively regulates hepcidin expression; loss-of-function mutations cause iron-refractory iron deficiency anemia (IRIDA) with inappropriately elevated hepcidin levels in both humans and mice.\",\n      \"method\": \"Human genetics (germline mutation identification), mouse phenotyping (Tmprss6-deficient mice), overexpression in cell lines with hepcidin promoter assays\",\n      \"journal\": \"Nature genetics / Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple independent labs simultaneously reported loss-of-function phenotype in humans and mice with concordant mechanistic findings\",\n      \"pmids\": [\"18408718\", \"18451267\", \"18523150\", \"18603562\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TMPRSS6 cleaves membrane-bound hemojuvelin (HJV) on the plasma membrane; the serine protease domain is required for this cleavage, and the MASK mouse allele (lacking the protease domain) shows no cleavage activity and fails to inhibit the hepcidin-activating BMP/SMAD pathway.\",\n      \"method\": \"Cell-based cleavage assay, co-expression of TMPRSS6 and HJV in cells, zebrafish overexpression, domain-deletion analysis\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — direct substrate cleavage demonstrated in vitro with mutant comparisons, replicated by multiple labs in complementary models\",\n      \"pmids\": [\"18976966\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TMPRSS6 interacts physically with HJV through its ectodomain; the MASK mutant (lacking protease domain) retains this interaction but loses cleavage activity, demonstrating that binding and proteolysis are separable functions.\",\n      \"method\": \"Co-immunoprecipitation, domain-deletion analysis, cell-based cleavage assay\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP binding data combined with functional cleavage assay, single lab\",\n      \"pmids\": [\"18976966\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Tmprss6 down-regulates BMP/SMAD signaling in the liver; mice deficient for both Tmprss6 and hemojuvelin (Hjv) exhibit iron overload similar to Hjv-single-knockout mice with markedly reduced hepcidin and Id1 mRNA, placing Tmprss6 activity upstream of HJV in the BMP/SMAD pathway.\",\n      \"method\": \"Genetic epistasis (double-knockout mice), hepatic mRNA analysis (Id1, hepcidin), iron phenotyping\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic epistasis in vivo with double-KO rescue experiment and molecular readout\",\n      \"pmids\": [\"20200349\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"IRIDA-associated missense mutations in the LDLRA domains of TMPRSS6 impair membrane targeting (causing Golgi retention) and abolish the autocatalytic activation cleavage required for protease activity, while a CUB domain mutation reduces but does not eliminate activation cleavage; all three mutants fail to fully repress hepcidin.\",\n      \"method\": \"cDNA transfection, subcellular localization (Golgi vs. plasma membrane), autocatalytic cleavage assay, hepcidin promoter reporter assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple orthogonal methods (localization, cleavage assay, promoter assay) in a single focused study\",\n      \"pmids\": [\"19357398\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"A Y141C mutation in the SEA domain of TMPRSS6 prevents autocatalytic self-activation of the protease while preserving membrane localization and HJV binding, demonstrating that SEA domain integrity is required for TMPRSS6 proteolytic activation.\",\n      \"method\": \"Site-directed mutagenesis, cell transfection, subcellular localization, HJV-binding assay, autocatalytic cleavage assay, hepcidin mRNA measurement\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution-level mutagenesis with multiple orthogonal functional readouts in a single study\",\n      \"pmids\": [\"20704562\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TMPRSS6 undergoes constitutive clathrin/AP-2-dependent, dynamin-dependent endocytosis in hepatocytes; specific residues in its N-terminal cytoplasmic domain are required for internalization. Mutants locked at the cell surface show sustained HJV cleavage and produce significantly less hepcidin, indicating that endocytic trafficking limits TMPRSS6 activity and is essential for normal iron homeostasis.\",\n      \"method\": \"Cell-surface labeling, clathrin/AP-2 co-localization, dynamin inhibition, site-directed mutagenesis of cytoplasmic tail, HJV cleavage assay, hepcidin measurement\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple orthogonal methods (localization, inhibitor, mutagenesis, functional assay) in one study\",\n      \"pmids\": [\"21724843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TMPRSS6 expression is positively regulated by BMP6 via the SMAD pathway (with ID1 as key mediator) and by iron loading in vivo; treatment with neutralizing anti-BMP6 antibody blocks Tmprss6 mRNA induction. This creates a negative feedback loop limiting excessive hepcidin increases.\",\n      \"method\": \"In vitro BMP6 treatment of hepatic cell lines (mRNA and protein levels, activity assay), in vivo iron loading and BMP6 injection in mice, anti-BMP6 antibody neutralization, siRNA knockdown of ID1\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — orthogonal in vitro and in vivo experiments in a single lab with genetic/pharmacologic perturbation\",\n      \"pmids\": [\"21622652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TMPRSS6 expression in hepatic cells is up-regulated by hypoxia via both HIF-1α and HIF-2α; HIF-dependent TMPRSS6 induction increases membrane HJV shedding and decreases hepcidin promoter responsiveness to BMP signaling.\",\n      \"method\": \"Hypoxia treatment of hepatic cell lines, HIF activator treatment, HIF1α/HIF2α overexpression, HJV shedding assay, hepcidin promoter reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple HIF isoforms tested with functional readouts, single lab\",\n      \"pmids\": [\"20966077\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"A functional hypoxia-responsive element (HRE) containing a HIF-1α binding site was identified in the TMPRSS6 promoter; mutation of this site abrogates HIF-1α-dependent induction of TMPRSS6 expression.\",\n      \"method\": \"TMPRSS6 promoter characterization, HRE mutagenesis, reporter assay, HIF-1α overexpression\",\n      \"journal\": \"Biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — direct promoter mutagenesis with functional reporter, single lab, single study\",\n      \"pmids\": [\"22628316\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Inflammation down-regulates TMPRSS6 expression in vitro and in vivo through decreased STAT5 phosphorylation (not via BMP/SMAD); STAT5 directly binds a response element in the Tmprss6 promoter and positively regulates its transcription.\",\n      \"method\": \"IL-6 treatment and LPS injection, STAT5 phosphorylation analysis, chromatin immunoprecipitation (STAT5 binding to Tmprss6 promoter), reporter assay, in vivo mouse experiments\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus in vivo and in vitro experiments with multiple readouts in a single study\",\n      \"pmids\": [\"24376517\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TMPRSS6 cleaves HJV at arginine residues 121 and 326 (in both full-length and heterodimeric HJV isoforms); mutagenesis of these arginines to alanine abolishes normal cleavage fragment release, while other arginines in the von Willebrand domain are insensitive, likely due to protein structure.\",\n      \"method\": \"Site-directed mutagenesis of HJV arginine residues, analysis of cleavage fragment patterns by western blot, co-expression with TMPRSS6, molecular dynamics simulation\",\n      \"journal\": \"Journal of cellular and molecular medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — direct mutagenesis of substrate cleavage sites with biochemical readout and structural modeling, single lab\",\n      \"pmids\": [\"25704252\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Double-knockout mice lacking both hemojuvelin and the matriptase-2 protease domain exhibit low Hamp expression and systemic iron overload, confirming that hemojuvelin is the major substrate for matriptase-2/TMPRSS6 proteolytic activity in vivo.\",\n      \"method\": \"Genetic epistasis (double-knockout mice), hepatic Hamp mRNA, serum/liver iron measurement\",\n      \"journal\": \"British journal of haematology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis in vivo; double-KO fully rescues iron overload, providing in vivo substrate validation\",\n      \"pmids\": [\"19751239\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Tmprss6 loss in Hfe(-/-) mice increases BMP/SMAD signaling in an HFE-independent manner; conversely, genetic loss of Hfe does not modify hepcidin elevation or iron deficiency in Tmprss6(-/-) mice, placing TMPRSS6 and HFE in partially parallel pathways that converge on BMP/SMAD signaling.\",\n      \"method\": \"Genetic epistasis (single and double-knockout mice), hepatic hepcidin/Id1 mRNA, iron phenotyping\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic epistasis experiments with molecular readout, single lab\",\n      \"pmids\": [\"21355094\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In vitro, the common TMPRSS6 V736A variant (rs855791 A allele) inhibits hepcidin more efficiently than the 736V form; in a genotyped population with normal iron stores, 736A homozygotes have significantly lower hepcidin and higher iron parameters, demonstrating that rs855791 is a functional variant modulating TMPRSS6 enzymatic activity.\",\n      \"method\": \"In vitro hepcidin promoter assay with V736A vs. V736V constructs, population-based serum hepcidin measurement stratified by genotype\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro functional assay plus human population data, single lab\",\n      \"pmids\": [\"21873547\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Liver hemojuvelin protein content is paradoxically decreased (not increased) in Tmprss6-deficient mice compared to wild-type, and hemojuvelin cleavage pattern is altered, providing in vivo evidence that TMPRSS6 interaction with HJV influences HJV protein stability/processing beyond simple shedding.\",\n      \"method\": \"Immunoblot of liver membrane fractions from Tmprss6(+/+) vs. Tmprss6(-/-) mice, phosphatidylinositol-specific phospholipase C treatment to confirm GPI anchoring, comparison with hemojuvelin-mutant negative controls\",\n      \"journal\": \"Blood cells, molecules & diseases\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — careful biochemical fractionation in vivo, single lab, somewhat counterintuitive result without full mechanistic resolution\",\n      \"pmids\": [\"21612955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Liver TMPRSS6 protein content is regulated post-transcriptionally: iron-deficient diet and erythropoietin treatment increase TMPRSS6 protein in rats and mice, while high doses of iron decrease it; intact hemojuvelin is required for stable TMPRSS6 membrane expression, as hemojuvelin-mutant mice show strongly decreased liver TMPRSS6 protein.\",\n      \"method\": \"Immunoblot of plasma membrane-enriched liver fractions, iron/EPO dosing in rodents, hemojuvelin-mutant mice comparison\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple conditions tested in vivo with biochemical readout, single lab\",\n      \"pmids\": [\"26845567\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Loss of hepatic TFR2 in Tmprss6(-/-) mice does not change the iron-deficiency anemia phenotype (unlike total Tfr2 loss), placing hepatic TFR2 upstream of TMPRSS6 in the hepcidin regulatory pathway. Loss of erythroid TFR2 in Tmprss6(-/-) mice causes relative erythrocytosis, revealing a separate erythroid role for TFR2 independent of TMPRSS6.\",\n      \"method\": \"Genetic epistasis (Tmprss6(-/-)Tfr2(-/-) and Tmprss6(-/-)Tfr2(LCKO) double-knockout mice), hepcidin expression, red cell and iron parameters\",\n      \"journal\": \"Haematologica\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic epistasis with liver-specific vs. total Tfr2 deletion, multiple molecular readouts, single lab\",\n      \"pmids\": [\"24658816\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TMPRSS6 isoforms 3 and 4 (catalytically impaired) reduce the proteolytic activity of the main isoform 2 and behave as dominant negatives; TMPRSS6 also cleaves transferrin receptor 1 (TfR1) from the cell surface, identifying TfR1 as an additional substrate.\",\n      \"method\": \"Co-expression assays in hepatic cell lines, protease activity measurement, co-immunoprecipitation to detect isoform interactions, cell-surface TfR1 shedding assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct biochemical assays and shedding assay, single lab, single study\",\n      \"pmids\": [\"36044454\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TMPRSS6 isoforms 1–4 all reach the cell surface, but only isoform 1 undergoes internalization; truncated isoform 3 and catalytically impaired isoform 4 interact with HJV and prevent its cleavage by isoform 2, acting as dominant-negative regulators.\",\n      \"method\": \"Heterologous expression in HEK293 and Hep3B cells, cell-surface trafficking assay, HJV cleavage assay, isoform interaction studies\",\n      \"journal\": \"Journal of cellular and molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — functional cell-based assays with multiple isoforms, single lab\",\n      \"pmids\": [\"29441715\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Small-molecule peptidomimetic and non-peptidic inhibitors of TMPRSS6 proteolytic activity block TMPRSS6-dependent hemojuvelin cleavage and increase HAMP expression and secreted hepcidin in HepG2 cells and human primary hepatocytes.\",\n      \"method\": \"In vitro protease inhibition assay, HJV cleavage assay in hepatic cell lines and primary human hepatocytes, HAMP mRNA and secreted hepcidin measurement\",\n      \"journal\": \"Cell chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — direct enzymatic inhibition confirmed in primary human hepatocytes with substrate cleavage and downstream hepcidin readout\",\n      \"pmids\": [\"31543462\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"FKBP12 downregulation in hepatocytes (by antisense oligonucleotide) up-regulates Tmprss6 expression, thereby counteracting ALK2-mediated BMP/SMAD activation and buffering hepcidin induction; combined downregulation of both Fkbp12 and Tmprss6 blocks this compensatory mechanism, revealing a functional crosstalk between FKBP12 and TMPRSS6 in hepcidin regulation.\",\n      \"method\": \"Antisense oligonucleotide knockdown in vivo, hepcidin and Tmprss6 mRNA measurement, BMP/SMAD signaling readout (SMAD phosphorylation, target genes)\",\n      \"journal\": \"American journal of physiology. Gastrointestinal and liver physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — in vivo ASO knockdown with molecular readouts, single lab, single study\",\n      \"pmids\": [\"38252872\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TMPRSS6 down-regulation in the liver (via GalNAc-ASO) activates BMP-SMAD signaling and enhances PPARα transcriptional activity, reducing hepatosteatosis, inflammation, and fibrosis in experimental MASLD mice; TMPRSS6 expression in human MASLD livers negatively correlates with PPARα signaling, uncovering a novel TMPRSS6–PPARα functional crosstalk.\",\n      \"method\": \"GalNAc-ASO knockdown in MASLD mouse model, transcriptome analysis, BMP-SMAD and PPARα pathway readouts, human liver expression correlation\",\n      \"journal\": \"Liver international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — in vivo ASO intervention with transcriptome profiling and pathway readouts, single lab, single study\",\n      \"pmids\": [\"40501083\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Matriptase-2 is expressed in the mouse retina, localized to the apical membrane of the retinal pigment epithelium (RPE) where its substrate hemojuvelin is also present; Tmprss6(msk/msk) knockout retinas are iron-deficient with upregulated hepcidin, and this retinal hepcidin upregulation occurs via IL-6/STAT3 signaling rather than BMP/SMAD signaling.\",\n      \"method\": \"RT-PCR, qPCR, immunofluorescence with apical/basolateral membrane markers, iron status markers (ferritin, TfR1), SMAD1/5/8 and STAT3 phosphorylation in Tmprss6(msk/msk) retinas\",\n      \"journal\": \"Molecular vision\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — multiple orthogonal assays in a single tissue/model, single lab\",\n      \"pmids\": [\"24791141\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"A human monoclonal antibody (REGN7999) that inhibits TMPRSS6 reduced liver iron, ineffective erythropoiesis, and improved RBC health in an Hbbth3/+ β-thalassemia mouse model; in a phase 1 human trial, REGN7999 increased serum hepcidin and reduced serum iron with acceptable tolerability, confirming the mechanistic role of TMPRSS6 inhibition in elevating hepcidin in vivo.\",\n      \"method\": \"Anti-TMPRSS6 mAb treatment in mouse β-thalassemia model (iron, erythropoiesis, bone density readouts) and phase 1 randomized controlled trial in healthy humans (pharmacodynamic readouts)\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — validated in mouse disease model plus human phase 1 clinical pharmacodynamics with mechanistic endpoint\",\n      \"pmids\": [\"40548380\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"TMPRSS6 encodes a type II transmembrane serine protease with a transmembrane domain, LDLRA domain, SRCR domain, and serine protease domain; it has substrate specificity slightly different from other TMPRSS family members and is strongly expressed in the thyroid.\",\n      \"method\": \"Molecular cloning, sequence analysis, expression profiling, substrate specificity assay\",\n      \"journal\": \"Molecules and cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Weak — initial biochemical characterization of domain structure and expression, single lab\",\n      \"pmids\": [\"15879706\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TMPRSS6 (matriptase-2) is a liver-expressed type II transmembrane serine protease that down-regulates hepcidin transcription by cleaving the BMP co-receptor hemojuvelin (at Arg121 and Arg326) from the hepatocyte surface, thereby suppressing BMP/SMAD signaling; its activity is tightly controlled by autocatalytic activation (requiring an intact SEA domain), constitutive clathrin-dependent endocytic removal from the plasma membrane, transcriptional induction by BMP6/iron (via SMAD/ID1) and HIF-1/2 under hypoxia, transcriptional repression by inflammation via decreased STAT5 phosphorylation, and dominant-negative regulation by catalytically impaired splice isoforms, with loss-of-function causing IRIDA and gain of TMPRSS6 suppression (by ASO, siRNA, or antibody) raising hepcidin and ameliorating iron overload and ineffective erythropoiesis in thalassemia and hemochromatosis models.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TMPRSS6 (matriptase-2) is a liver-expressed type II transmembrane serine protease that serves as the principal negative regulator of the iron-regulatory hormone hepcidin, and its loss of function causes iron-refractory iron deficiency anemia (IRIDA) with inappropriately elevated hepcidin [#0]. Mechanistically, TMPRSS6 cleaves the BMP co-receptor hemojuvelin (HJV) from the hepatocyte surface—at arginine residues 121 and 326—thereby damping BMP/SMAD signaling and lowering hepcidin transcription; the serine protease domain is required, and binding to HJV is separable from cleavage [#1, #2, #11]. In vivo genetic epistasis establishes that TMPRSS6 acts upstream of HJV in the BMP/SMAD/ID1 pathway, with HJV being its major physiological substrate, and that it converges on BMP/SMAD in parallel with, and downstream of, HFE and hepatic TFR2 [#3, #12, #13, #17]. TMPRSS6 activity is tightly constrained: it requires autocatalytic self-activation that depends on intact SEA and LDLRA domains, and IRIDA mutations in these domains block activation or membrane targeting and fail to repress hepcidin [#4, #5]; constitutive clathrin/AP-2- and dynamin-dependent endocytosis via the cytoplasmic tail limits surface activity, since surface-locked mutants over-cleave HJV and suppress hepcidin excessively [#6]. Transcription is induced by BMP6/iron through SMAD/ID1 as a negative feedback loop and by hypoxia through HIF-1α/HIF-2α acting at a promoter HRE, while inflammation represses it through reduced STAT5 phosphorylation [#7, #8, #9, #10]. Pharmacological suppression of TMPRSS6—by small-molecule protease inhibitors or an inhibitory monoclonal antibody—raises hepcidin, lowers serum and liver iron, and improves ineffective erythropoiesis in β-thalassemia models and in human phase 1 testing, validating it as a therapeutic target [#20, #24].\",\n  \"teleology\": [\n    {\n      \"year\": 2008,\n      \"claim\": \"Established TMPRSS6 as a physiological negative regulator of hepcidin, answering why its deficiency produces iron-deficiency anemia.\",\n      \"evidence\": \"Human germline mutation identification, Tmprss6-deficient mouse phenotyping, and hepcidin promoter assays\",\n      \"pmids\": [\"18408718\", \"18451267\", \"18523150\", \"18603562\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the direct molecular substrate\", \"Did not resolve how the protease lowers hepcidin transcription\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified the direct molecular mechanism—cleavage of membrane HJV—and showed protease-dependent suppression of BMP/SMAD signaling, while distinguishing binding from proteolysis.\",\n      \"evidence\": \"Cell-based HJV cleavage and co-IP assays, domain-deletion (MASK) analysis, zebrafish overexpression\",\n      \"pmids\": [\"18976966\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Exact cleavage sites on HJV not yet mapped\", \"Binding interface on HJV undefined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined how IRIDA mutations disable the enzyme, localizing activation control to the LDLRA (membrane targeting and autocatalysis) and CUB domains.\",\n      \"evidence\": \"cDNA transfection with subcellular localization, autocatalytic cleavage, and hepcidin reporter assays\",\n      \"pmids\": [\"19357398\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of LDLRA-dependent trafficking not resolved\", \"Activating protease/protease(s) for autocatalysis not identified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Confirmed in vivo that HJV is the major substrate by genetic epistasis, since double knockout recapitulates HJV-loss iron overload.\",\n      \"evidence\": \"Tmprss6/Hjv double-knockout mice with hepatic Hamp mRNA and iron measurement\",\n      \"pmids\": [\"19751239\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not exclude additional minor substrates\", \"Quantitative contribution of HJV cleavage vs. stability changes unclear\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Placed TMPRSS6 upstream of HJV within the BMP/SMAD/ID1 axis through clean epistasis.\",\n      \"evidence\": \"Tmprss6/Hjv double-knockout mice, hepatic Id1 and hepcidin mRNA\",\n      \"pmids\": [\"20200349\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address parallel inputs (HFE, TFR2)\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Showed SEA domain integrity is required for autocatalytic self-activation, separating activation from membrane localization and substrate binding.\",\n      \"evidence\": \"Y141C site-directed mutagenesis with localization, HJV binding, autocatalytic cleavage, and hepcidin readouts\",\n      \"pmids\": [\"20704562\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trigger of autocatalysis under physiological conditions unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Revealed hypoxia as a transcriptional input, linking oxygen sensing to TMPRSS6-mediated hepcidin suppression via HIF-1α/HIF-2α.\",\n      \"evidence\": \"Hypoxia and HIF activator treatment, HIF overexpression, HJV shedding and hepcidin reporter assays\",\n      \"pmids\": [\"20966077\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Promoter element not yet localized in this study\", \"Relative roles of HIF-1α vs HIF-2α in vivo unclear\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Mapped the BMP6/iron feedback loop, showing TMPRSS6 is itself a SMAD/ID1 target that limits excessive hepcidin.\",\n      \"evidence\": \"BMP6 and iron treatment in vitro and in vivo, anti-BMP6 neutralization, ID1 siRNA\",\n      \"pmids\": [\"21622652\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct SMAD/ID1 binding to the Tmprss6 promoter not delineated here\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identified constitutive clathrin/AP-2/dynamin-dependent endocytosis as a brake on surface protease activity essential for iron homeostasis.\",\n      \"evidence\": \"Cell-surface labeling, clathrin/AP-2 co-localization, dynamin inhibition, cytoplasmic-tail mutagenesis, HJV cleavage and hepcidin assays\",\n      \"pmids\": [\"21724843\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Post-endocytic fate (recycling vs degradation) not defined\", \"Regulation of internalization rate by iron status not established\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Resolved that TMPRSS6 and HFE act in partially parallel pathways converging on BMP/SMAD, clarifying genetic interactions.\",\n      \"evidence\": \"Single and double Hfe/Tmprss6 knockout mice with hepcidin/Id1 mRNA and iron phenotyping\",\n      \"pmids\": [\"21355094\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular point of convergence on BMP/SMAD undefined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showed the common V736A variant (rs855791) is a functional modifier of TMPRSS6 enzymatic efficiency, linking genotype to human iron parameters.\",\n      \"evidence\": \"In vitro hepcidin reporter assay with V736A vs V736V, genotype-stratified population hepcidin data\",\n      \"pmids\": [\"21873547\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of altered activity unresolved\", \"Effect size in disease populations not addressed\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Revealed an unexpected reciprocal dependence: HJV protein content and processing are altered in TMPRSS6-deficient liver, implying TMPRSS6 influences HJV stability beyond shedding.\",\n      \"evidence\": \"Immunoblot of liver membrane fractions with PI-PLC treatment and HJV-mutant controls\",\n      \"pmids\": [\"21612955\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of paradoxical HJV decrease not resolved\", \"Counterintuitive result without full mechanistic explanation\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Localized the functional HRE in the TMPRSS6 promoter, confirming direct HIF-1α-dependent transcriptional control.\",\n      \"evidence\": \"Promoter HRE mutagenesis with reporter assay and HIF-1α overexpression\",\n      \"pmids\": [\"22628316\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo occupancy of the HRE not demonstrated\", \"Single study, single lab\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Defined the inflammatory repression pathway, showing TMPRSS6 is positively regulated by STAT5 and downregulated when STAT5 phosphorylation falls during inflammation.\",\n      \"evidence\": \"IL-6/LPS treatment, STAT5 phosphorylation analysis, ChIP for STAT5 on Tmprss6 promoter, reporter and in vivo experiments\",\n      \"pmids\": [\"24376517\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signal coupling inflammation to STAT5 dephosphorylation not detailed\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Positioned hepatic TFR2 upstream of TMPRSS6 and uncovered a separate erythroid TFR2 role, refining the pathway hierarchy.\",\n      \"evidence\": \"Tmprss6/Tfr2 and Tmprss6/Tfr2(LCKO) double-knockout mice with hepcidin and red-cell parameters\",\n      \"pmids\": [\"24658816\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Biochemical interaction between TFR2 and TMPRSS6 not shown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Extended TMPRSS6/HJV function beyond liver to the retinal pigment epithelium, where hepcidin regulation uses IL-6/STAT3 rather than BMP/SMAD.\",\n      \"evidence\": \"RT-PCR/qPCR, immunofluorescence with membrane markers, iron and signaling readouts in Tmprss6(msk/msk) retinas\",\n      \"pmids\": [\"24791141\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological importance of retinal TMPRSS6 unclear\", \"Tissue-specific signaling switch mechanism unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Mapped the precise HJV cleavage sites (Arg121, Arg326), defining substrate specificity at residue resolution.\",\n      \"evidence\": \"Site-directed mutagenesis of HJV arginines, cleavage fragment analysis, molecular dynamics simulation\",\n      \"pmids\": [\"25704252\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Order/kinetics of dual cleavage not established\", \"Structural enzyme-substrate complex not solved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showed TMPRSS6 protein is regulated post-transcriptionally by iron and EPO and depends on intact HJV for stable membrane expression.\",\n      \"evidence\": \"Immunoblot of plasma-membrane liver fractions under iron/EPO dosing and in HJV-mutant mice\",\n      \"pmids\": [\"26845567\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular basis of HJV-dependent TMPRSS6 stabilization unknown\", \"Link to EPO signaling unresolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identified dominant-negative splice isoforms and a second substrate (TfR1), expanding the regulatory and substrate repertoire.\",\n      \"evidence\": \"Co-expression and protease activity assays, co-IP of isoform interactions, surface TfR1 and HJV shedding assays in hepatic and HEK293 cells\",\n      \"pmids\": [\"36044454\", \"29441715\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological relevance of TfR1 cleavage in vivo not shown\", \"In vivo abundance and impact of isoforms 3/4 unquantified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrated druggability of the protease, with small-molecule inhibitors blocking HJV cleavage and raising hepcidin in primary human hepatocytes.\",\n      \"evidence\": \"In vitro protease inhibition, HJV cleavage assay, HAMP/hepcidin readouts in HepG2 and primary human hepatocytes\",\n      \"pmids\": [\"31543462\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo efficacy and selectivity of these compounds not addressed in this study\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Revealed FKBP12-TMPRSS6 crosstalk, where FKBP12 loss raises Tmprss6 to buffer ALK2-driven BMP/SMAD activation.\",\n      \"evidence\": \"In vivo ASO knockdown of Fkbp12 and Tmprss6 with hepcidin/Tmprss6 mRNA and SMAD signaling readouts\",\n      \"pmids\": [\"38252872\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct mechanism linking FKBP12 to Tmprss6 transcription unknown\", \"Single study, single lab\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Uncovered a TMPRSS6-PPARα axis, where hepatic TMPRSS6 suppression activates BMP-SMAD and PPARα to ameliorate steatohepatitis, broadening its role beyond iron homeostasis.\",\n      \"evidence\": \"GalNAc-ASO knockdown in MASLD mice with transcriptomics and pathway readouts, plus human liver expression correlation\",\n      \"pmids\": [\"40501083\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanistic link between BMP-SMAD and PPARα not defined\", \"Single study, single lab\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Provided in vivo and human clinical validation of TMPRSS6 inhibition as a hepcidin-raising therapy for iron-loading anemia.\",\n      \"evidence\": \"Anti-TMPRSS6 mAb (REGN7999) in Hbbth3/+ β-thalassemia mice and a phase 1 randomized trial with pharmacodynamic endpoints\",\n      \"pmids\": [\"40548380\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Long-term efficacy and clinical outcomes in patients not yet established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How TMPRSS6 surface activity is dynamically tuned by iron and erythropoietic signals—integrating autocatalytic activation, endocytic turnover, HJV-dependent stability, and isoform dominant-negative effects into a single quantitative control model—remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of the active enzyme-HJV complex\", \"Physiological trigger of autocatalytic activation undefined\", \"In vivo significance of TfR1 cleavage and splice isoforms unquantified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [1, 4, 5, 11, 18, 20]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [1, 11, 25]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 6, 16, 25]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 3, 12]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 7, 13]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [7, 9, 10]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"HJV\", \"TFR1\", \"FKBP12\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}